TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,125 | +50.2% | 750,000 | 0.0% | 0.07% | +59.5% |
| Q4 2022 | $749 | -99.9% | 750,000 | 0.0% | 0.04% | -27.6% |
| Q3 2022 | $1,350,000 | -37.9% | 750,000 | 0.0% | 0.06% | -50.0% |
| Q2 2022 | $2,175,000 | +5.1% | 750,000 | 0.0% | 0.12% | +33.3% |
| Q1 2022 | $2,070,000 | -40.8% | 750,000 | 0.0% | 0.09% | -8.4% |
| Q4 2021 | $3,495,000 | -45.2% | 750,000 | 0.0% | 0.10% | -33.6% |
| Q3 2021 | $6,383,000 | -48.1% | 750,000 | 0.0% | 0.14% | -42.8% |
| Q2 2021 | $12,308,000 | -25.7% | 750,000 | 0.0% | 0.25% | -14.7% |
| Q1 2021 | $16,560,000 | +7.1% | 750,000 | +50.0% | 0.29% | -11.7% |
| Q4 2020 | $15,465,000 | +52.2% | 500,000 | 0.0% | 0.33% | +34.4% |
| Q3 2020 | $10,160,000 | +89.0% | 500,000 | +42.9% | 0.25% | +64.7% |
| Q2 2020 | $5,376,000 | +73.6% | 350,000 | -12.5% | 0.15% | +14.5% |
| Q1 2020 | $3,096,000 | -45.8% | 400,000 | 0.0% | 0.13% | -40.7% |
| Q4 2019 | $5,712,000 | -19.5% | 400,000 | -15.2% | 0.22% | -22.2% |
| Q3 2019 | $7,092,000 | +1.1% | 471,846 | -3.7% | 0.28% | 0.0% |
| Q2 2019 | $7,012,000 | -17.9% | 490,000 | 0.0% | 0.28% | -18.6% |
| Q1 2019 | $8,541,000 | – | 490,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|